 | -$0.11 Earnings Per Share Expected for SCYNEXIS Inc (NASDAQ:SCYX) This Quarter
www.americanbankingnews.com - July 9 at 4:18 PM |
 | SCYNEXIS to Host A Key Opinion Leader Discussion on the Immediate Need in Treating Women with Vaginal Yeast Infections - GlobeNewswire
www.globenewswire.com - July 9 at 1:02 PM |
 | SCYNEXIS to Host A Key Opinion Leader Discussion on the Immediate Need in Treating Women with Vaginal Yeast Infections
finance.yahoo.com - July 9 at 1:02 PM |
| SCYNEXIS Inc (NASDAQ:SCYX) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - June 18 at 2:38 AM |
| Analysts Expect SCYNEXIS Inc (NASDAQ:SCYX) Will Post Earnings of -$0.11 Per Share
www.americanbankingnews.com - June 17 at 11:12 AM |
| SCYNEXIS to Present at the BIO Digital International Convention 2020 - GlobeNewswire
www.globenewswire.com - June 8 at 6:07 PM |
| SCYNEXIS to Present at the BIO Digital International Convention 2020
finance.yahoo.com - June 8 at 12:57 PM |
| SCYNEXIS Inc (SCYX): Are Hedge Funds Right About This Stock? - Yahoo Finance
finance.yahoo.com - June 4 at 11:08 PM |
| SCYNEXIS Strengthens Leadership Team with Appointment of Jim Maffezzoli as Vice President of Marketing and Sales - GlobeNewswire
www.globenewswire.com - June 2 at 1:25 PM |
| SCYNEXIS Strengthens Leadership Team with Appointment of Jim Maffezzoli as Vice President of Marketing and Sales
finance.yahoo.com - June 2 at 1:25 PM |
|
 | 3 ‘Strong Buy’ Biotech Stocks Under $5 That Could Go Boom - Nasdaq
www.nasdaq.com - June 1 at 2:32 PM |
| Scynexis: 1Q Earnings Snapshot - Yahoo Finance
finance.yahoo.com - May 12 at 2:24 AM |
| SCYNEXIS Reports First Quarter 2020 Financial Results and Provides Company Update - GlobeNewswire
www.globenewswire.com - May 11 at 9:24 PM |
| SCYNEXIS Reports First Quarter 2020 Financial Results and Provides Company Update
finance.yahoo.com - May 11 at 4:19 PM |
| SCYNEXIS Announces Six Abstracts Published by 30th ECCMID Highlighting the Potential Clinical Utility of Ibrexafungerp - GlobeNewswire
www.globenewswire.com - May 6 at 1:01 PM |
| SCYNEXIS Announces Six Abstracts Published by 30th ECCMID Highlighting the Potential Clinical Utility of Ibrexafungerp
finance.yahoo.com - May 6 at 1:01 PM |
 | SCYNEXIS, Inc. S-3 May. 1, 2020 4:01 PM - Seeking Alpha
seekingalpha.com - May 2 at 10:10 AM |
 | BRIEF-Scynexis Inc Files For Offering Of Up To 19.4 Million Shares Of Common Stock By Selling Stockholder - SEC Filing - Reuters
www.reuters.com - May 1 at 7:07 PM |
| SCYNEXIS to Participate in Antifungals Panel at Maxim Group's Infectious Disease Virtual Conference: The Renaissance of the Anti-infective Sector - GlobeNewswire
www.globenewswire.com - April 29 at 4:28 AM |
| SCYNEXIS to Participate in Antifungals Panel at Maxim Group’s Infectious Disease Virtual Conference: The Renaissance of the Anti-infective Sector - Yahoo Finance
finance.yahoo.com - April 28 at 8:25 AM |
| SCYNEXIS to Participate in Antifungals Panel at Maxim Group’s Infectious Disease Virtual Conference: The Renaissance of the Anti-infective Sector
finance.yahoo.com - April 28 at 8:25 AM |
 | How Does SCYNEXIS, Inc. (NASDAQ:SCYX) Affect Your Portfolio Volatility? - Yahoo Finance UK
uk.finance.yahoo.com - April 27 at 10:24 PM |
| How Does SCYNEXIS, Inc. (NASDAQ:SCYX) Affect Your Portfolio Volatility?
finance.yahoo.com - April 27 at 5:23 PM |
| BRIEF-Scynexis Says Ibrexafungerp Was Generally Safe And Well-Tolerated - Reuters
www.reuters.com - April 21 at 8:44 AM |
| Scynexis up 20% premarket on second positive study of ibrexafungerp - Seeking Alpha
seekingalpha.com - April 21 at 8:44 AM |
| SCYNEXIS Announces Positive Top-Line Results from its Second Pivotal Phase 3 Study (VANISH-306) of Oral Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis (Vaginal Yeast Infection)
finance.yahoo.com - April 21 at 8:44 AM |
|
| Scynexis closes $20M stock purchase deal - Seeking Alpha
seekingalpha.com - April 13 at 11:07 PM |
| BRIEF-Scynexis, Aspire Capital Enter $20 Mln Common Stock Purchase Agreement - Reuters
www.reuters.com - April 13 at 1:06 PM |
 | Form 8-K SCYNEXIS INC For: Apr 10 - StreetInsider.com
www.streetinsider.com - April 13 at 1:06 PM |
| SCYNEXIS and Aspire Capital Enter into $20 Million Common Stock Purchase Agreement - GlobeNewswire
www.globenewswire.com - April 13 at 1:06 PM |
| SCYNEXIS and Aspire Capital Enter into $20 Million Common Stock Purchase Agreement
finance.yahoo.com - April 13 at 1:06 PM |
| Scynexis shores up finances with $10M convertible debt deal - Seeking Alpha
seekingalpha.com - April 9 at 2:49 PM |
| SCYNEXIS Secures $10 Million in Financing through Senior Convertible Note Purchase Agreement with Puissance Capital - Yahoo Finance
finance.yahoo.com - April 9 at 9:49 AM |
| SCYNEXIS Secures $10 Million in Financing through Senior Convertible Note Purchase Agreement with Puissance Capital
finance.yahoo.com - April 9 at 9:48 AM |
| SCYNEXIS to Virtually Present on the Candida Auris Treatment Landscape at the 22nd Annual Superbugs and Superdrugs Conference 2020 - GlobeNewswire
www.globenewswire.com - March 26 at 2:07 PM |
| SCYNEXIS to Virtually Present on the Candida Auris Treatment Landscape at the 22nd Annual Superbugs and Superdrugs Conference 2020 - Yahoo Finance
finance.yahoo.com - March 26 at 9:07 AM |
| SCYNEXIS to Virtually Present on the Candida Auris Treatment Landscape at the 22nd Annual Superbugs and Superdrugs Conference 2020
finance.yahoo.com - March 26 at 9:07 AM |
| Earnings Update: SCYNEXIS, Inc. Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance
finance.yahoo.com - March 13 at 9:28 PM |
| Earnings Update: SCYNEXIS, Inc. Just Reported And Analysts Are Boosting Their Estimates
finance.yahoo.com - March 13 at 4:27 PM |
| SCYNEXIS Reports Full Year 2019 Financial Results and Provides Company Update - GlobeNewswire
www.globenewswire.com - March 11 at 8:30 AM |
| SCYNEXIS Reports Full Year 2019 Financial Results and Provides Company Update
finance.yahoo.com - March 11 at 8:30 AM |
| BRIEF-SCYNEXIS Announces Preclinical Data On Ibrexafungerp And Azoles Against Aspergillus Presented At The 9Th Advances Against Aspergillosis And Mucormycosis Conference - Reuters
www.reuters.com - March 5 at 2:04 PM |
| Scynexis (SCYX) Announces Preclinical Data on Ibrexafungerp and Azoles against Aspergillus Presented at Conference - StreetInsider.com
www.streetinsider.com - March 5 at 9:03 AM |
| SCYNEXIS Announces Preclinical Data on Ibrexafungerp and Azoles against Aspergillus Presented at the 9th Advances Against Aspergillosis and Mucormycosis Conference - Yahoo Finance
finance.yahoo.com - March 5 at 9:03 AM |
| SCYNEXIS Announces Preclinical Data on Ibrexafungerp and Azoles against Aspergillus Presented at the 9th Advances Against Aspergillosis and Mucormycosis Conference
finance.yahoo.com - March 5 at 9:03 AM |
| SCYNEXIS, Inc. Common Stock (SCYX) Revenue EPS
www.nasdaq.com - February 24 at 12:04 AM |
 | BRIEF-Scynexis Completes Patient Enrollment In Study Of Vaginal Yeast Infection Treatment
www.msn.com - February 15 at 12:54 AM |
| Form SC 13G/A SCYNEXIS INC Filed by: CAXTON CORP - StreetInsider.com
www.streetinsider.com - February 14 at 7:53 PM |
| BRIEF-Scynexis Completes Patient Enrollment In Study Of Vaginal Yeast Infection Treatment - Reuters
www.reuters.com - February 13 at 12:14 PM |
| Scynexis completes enrollment in second pivotal study of ibrexafungerp - Seeking Alpha
seekingalpha.com - February 13 at 12:14 PM |
